| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |